The drug, bought only because a bribe was paid, is not useful or even worse, harmful, for those who are ill. The Anac led by Cantone: the administrations are improving but there are too many shortcomings in the prevention plans.
Here are two of the last frontiers of malfeasance in healthcare in Italy. Controlled waiting lists and counterfeit medicines: these are just two examples, extreme but unfortunately real, put on paper in a dossier by Anac, the National Anti-Corruption Authority chaired by Raffaele Cantone, and carried out in close collaboration with the Ministries of Health and the Economy, and with Agenas, the National Agency for Regional Health Services whose new head of Anti-corruption has been Lucia Borsellino, the former Sicilian regional councilor for Health since 1 September .
A monitoring concluded in July 2015, which offers two-sided data: il 96% di enti ha adottato formalmente i piani anticorruzione e il 62% ha «adottato e pubblicato l’aggiornamento per il triennio 2015-2017». Ma in realtà, nota l’Anac, «la qualità dei ”Piani di prevenzione della corruzione” è generalmente insoddisfacente e risulta influenzata da alcune variabili di contesto, quali la tipologia di amministrazioni, la collocazione geografica delle stesse e la dimensione organizzativa».
Related news: Annual Report to the Parliament of the National Anti-Corruption Authority for the year 2014 presented by the President Raffaele Cantone.
Chamber of Deputies, Sala della Regina, 2 July 2015
Speech by the President of the ANAC. Raffaele Cantone
From public contracts to appointments, here is the anti-corruption plan in healthcare